false
0000948320
0000948320
2026-09-15
2026-09-15
0000948320
LFMD:CommonStockParValue0.01PerShareMember
2026-09-15
2026-09-15
0000948320
LFMD:Sec8.875SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember
2026-09-15
2026-09-15
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities and Exchange Act of 1934
Date
of Report (Date of earliest event reported): September 15, 2026
LIFEMD,
INC.
(Exact
name of Registrant as specified in its charter)
| Delaware |
|
001-39785 |
|
76-0238453 |
(State
or other jurisdiction
of
incorporation) |
|
(Commission
File
Number) |
|
(IRS
Employer
Identification
No.) |
236
Fifth Avenue, Suite 400
New
York, NY 10001
(Address
of principal executive offices, including zip code)
(866)
351-5907
(Registrant’s
telephone number, including area code)
Check
the appropriate box below if the 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any
of the following provisions:
| ☐ |
Written
communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)). |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Common
Stock, par value $0.01 per share |
|
LFMD |
|
The
Nasdaq Global Market |
| 8.875%
Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share |
|
LFMDP |
|
The
Nasdaq Global Market |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
7.01 Regulation FD Disclosure.
On
September 15, 2026, LifeMD, Inc. (the “Company” or “LifeMD”) announced an exclusive strategic collaboration with
AT&T Services, Inc. (“AT&T”), whereby eligible AT&T wireless and fiber customers receive a complimentary LifeMD
membership.
The
parties entered into a Subscriber Health & Wellness Collaboration Agreement, providing for a multi-phase launch that will initially
cover a limited number of states and then expand into a nationwide offering. The Company initially will pay AT&T a fixed fee per
lead, with subsequent compensation to be negotiated. The parties will establish a joint steering committee to provide strategic oversight
and governance of the project and the parties’ respective obligations, including marketing, budget, creative, pricing, performance,
and dispute resolution.
Subject
to earlier termination under certain circumstances, the Agreement has an initial term of one year with automatic renewal for successive
one-year periods unless either party provides 90 days’ written notice of non-renewal. The agreements contain customary representations,
warranties and covenants by each of the parties, and indemnification provisions under which the parties have agreed, subject to certain
limitations, to indemnify each other against certain liabilities.
The
Company issued a press release announcing the exclusive partnership. A copy of the Company’s press release is attached hereto as
Exhibit 99.1 and is incorporated by reference herein.
The
Company makes no admission as to the materiality of any information in this Current Report on Form 8-K, including the press release,
that is required to be disclosed solely by reason of Regulation FD. The Company undertakes no duty or obligation to publicly update or
revise the information contained in this Current Report on Form 8-K, although it may do so from time to time as its management believes
is warranted. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases or
through other public disclosure.
The
information provided under this Item 7.01 of this Current Report on Form 8-K, including the press release, is “furnished”
and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed
incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall
be expressly set forth by specific reference in such filing.
Cautionary
Statements Regarding Forward-Looking Information
This
Current Report on Form 8-K, including the press release, contains forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995, including, without limitation, statements regarding the expected launch timing, scope, pricing, and benefits
of the AT&T strategic collaboration; the duration of the program; the number of states in which the program will be available and
any potential expansion; the parties’ planned promotional and consumer education initiatives; expected patient demand and access;
and the anticipated benefits of the collaboration to patients and to each company. Words such as “expect,” “believe,”
“will,” “designed to,” “anticipate,” and similar expressions identify forward-looking statements.
These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual
results to differ materially, including risks related to the commercial launch and adoption of the program, changes in federal or state
laws governing telehealth prescribing of controlled substances, regulatory and compliance requirements applicable to telehealth, pharmacy,
and pharmaceutical promotion, and the other risks described in each company’s filings with the Securities and Exchange Commission,
including LifeMD’s most recent Annual Reports on Form 10-K and subsequent Quarterly Reports on Form 10-Q. The Company does not
undertake any obligation to update forward-looking statements except as required by law.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
Exhibit
No. |
|
Description |
| 99.1 |
|
Press Release dated September 15, 2026 |
| 104 |
|
Cover
Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| |
|
LIFEMD,
INC. |
| |
|
|
| Dated: |
September
15, 2026 |
By: |
/s/
Eric Yecies |
| |
|
|
Chief
Legal Officer and General Counsel |
Exhibit
99.1
DALLAS,
September 15, 2026
AT&T
Becomes the First and Only Carrier to Offer Free Access to Virtual Healthcare Powered by LifeMD
Through
an exclusive collaboration with LifeMD, eligible AT&T wireless and fiber customers receive a complimentary LifeMD membership, a $228
annual value, with on-demand access to a nationwide virtual care and pharmacy platform.

Key
Takeaways:
| ● | More
than 100 million eligible AT&T wireless and fiber customers will receive complimentary
access to LifeMD’s virtual care and pharmacy platform. |
| | | |
| ● | The
$19-per-month LifeMD membership fee will be fully waived, a value of $228 per year. |
| | | |
| ● | Members
can connect with providers for everyday health needs and prescriptions, with many medications
shipped directly from LifeMD’s pharmacy. |
| | | |
| |
● |
The benefit is available
through AT&T’s &More program, which allows members to unlock savings and special offers. |
What’s
the News: AT&T is delivering more value to eligible wireless and fiber customers through an exclusive collaboration with LifeMD,
a leading virtual care and pharmacy services provider. Eligible customers receive a complimentary LifeMD membership, connecting them
to a nationwide virtual care and pharmacy platform that offers convenient access to healthcare from virtually anywhere.

Why
it Matters: More people are turning to virtual care to get the healthcare they need. A recent study revealed 82% of patients
said telemedicine helps them stay on track with their health, while 78% said it makes healthcare easier to access. Through LifeMD, AT&T
is helping remove barriers to care and medication access, giving customers a simpler way to manage their health.
Quotable:
“AT&T connects customers to the things that matter most, and healthcare is one of them. As virtual care becomes an increasingly
important option, this offer gives eligible customers a simpler, more accessible way to manage their well-being,” said Jenifer
Robertson, executive vice president & GM, AT&T Consumer. “Together with LifeMD, we’re using connectivity to expand
access to care and help more people get support when and where they need it.”
“AT&T
connects tens of millions of households across the country, and together we’re making something new available to them: a complete
virtual care and pharmacy experience,” said Justin Schreiber, Chairman and CEO of LifeMD. “This is a landmark moment
for LifeMD and, more importantly, for the millions of Americans who have been priced out of convenient, high-quality healthcare. Members
can reach a state-licensed provider from their phone at their convenience and get care for a wide range of everyday health needs. We’ve built the healthcare platform today’s consumer wants, and this collaboration puts it in front of one
of the largest customer bases in America.”
More
Details: Eligible customers must enroll to receive a complimentary LifeMD membership, helping put convenient care within reach without
a monthly fee. Once enrolled, customers can choose the care that meets their needs and pay only for the visits, prescriptions, or services
they use.
29
million AT&T customers in 11 states will be the first to receive this new benefit, with additional markets joining in January 2027
as it expands nationwide. Customers can learn more and enroll through the AT&T website or the AT&T mobile app.
Frequently
Asked Questions:
| ● | Q:
Who is eligible* for the LifeMD benefit? |
| ○ | All
current AT&T wireless and fiber customers are eligible for complimentary access to LifeMD’s
virtual care and pharmacy platform. The benefit will initially be available in select states
(AZ, FL, NC, IL, MD, NM, IA, TX, NY, CA, and MI), with expansion to additional states planned
for January 2027. |
*Not all offerings are available in all states. Customers must be 18 or older. Some offerings may have additional eligibility restrictions.
| ● | Q:
What does “complimentary access” include? |
| ○ | AT&T
customers receive LifeMD membership at no cost, with the $19 monthly membership fee fully
waived. Members pay only for the care they need, with visits starting at $29 for message-based
care, $49 for urgent and primary care video visits with state-licensed providers, and $79
for specialty care. For visits and prescriptions, customers can choose to use insurance,
Medicare, or discounted cash-pay rates. AT&T customers will have access to LifeMD’s
nationwide virtual care and pharmacy platform, including: |
| ■ | Virtual
primary care and 24/7 urgent care, with same-day prescriptions for common conditions like
infections, allergies, and asthma |
| ■ | Ongoing
medications for chronic conditions such as high blood pressure and high cholesterol |
| ■ | Weight
management, including GLP-1 medications |
| ■ | Women’s
health, including perimenopause and menopause care and hormone replacement therapy |
| ■ | Men’s
health, including testosterone and sexual health treatment |
| ■ | Prescription
dermatology, hormone health, sleep, and laboratory services |
| ■ | Same-day
prescriptions and refills, when clinically appropriate, with many medications shipped directly
from LifeMD’s pharmacy and others sent to the member’s local pharmacy |
| ● | Q:
How do customers sign up for the benefit? |
| ○ | Customers
can learn more about the benefit and enroll through the AT&T website, mobile app,
and other digital channels. Once enrolled, they can use the LifeMD platform to connect with
state-licensed providers, fill and manage prescriptions through LifeMD’s pharmacy,
and access a range of virtual care services. |
1
Limited time offer. Only monthly fee waived; costs of care, visits, and prescriptions not included. Not available in all states. Customers
must be 18 or older. Additional restrictions and requirements may apply. See here for more details, terms, and conditions.
About
AT&T
We
help more than 100 million U.S. families, friends and neighbors, plus nearly 2.5 million businesses, connect to greater possibility.
From the first phone call 150 years ago to our 5G wireless and multi-gig internet offerings today, we @ATT innovate to improve lives.
For more information about AT&T Inc. (NYSE:T), please visit us at about.att.com. Investors can learn more at investors.att.com.
About
LifeMD
LifeMD®
(Nasdaq: LFMD) is a leading virtual care company making high-quality healthcare more accessible, convenient, and affordable. Through
its vertically integrated platform, LifeMD connects patients with a 50-state affiliated medical group, laboratory services, a state-of-the-art
nationwide pharmacy with home delivery, and a U.S.-based patient care center. Together, these capabilities support care across more than
200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. For more information,
please visit LifeMD.com.